// App-Quantinova.ai

Su1869 : PREOPERATIVE USTEKINUMAB TREATMENT IS NOT ASSOCIATED WITH INCREASED POSTOPERATIVE COMPLICATIONS IN Crohn's DISEASE: A CANADIAN MULTICENTRE CASE-CONTROL COHORT STUDY

Researchers

Presenter

  • Christopher Ma

Principal Investigators

  • Heba Al-Farhan

  • Karen I. Kroeker

  • Brendan P. Halloran

  • Remo Panaccione

  • Ahmed Al-Darmaki

  • Jack X. Pang

  • Cynthia H. Seow

  • Richard N. Fedorak

  • Shane M. Devlin

  • Levinus A. Dieleman

  • Gilaad Kaplan

  • Kerri L. Novak

Medical Centers

  • Hepatology, University of Alberta, Edmonton, Alberta, Canada

  • Gastroenterology & Hepatology, Singapore General Hospital, Singapore, Singapore

  • Gastroenterology, University of Calgary, Calgary, Alberta, Canada

Locations

  • Canada

  • Singapore

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Human albumin

  • Interleukin 12

Drug/Treatment

  • Oraprine

  • Methotrexate

  • Ustekinumab

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved